Keeping Track Novartis Scores Big Ahead Of US Memorial Day With Approvals For Gene Therapy Zolgensma Oncologic Piqray
Keeping Track: Novartis Scores Big Ahead Of US Memorial Day With Approvals For Gene Therapy Zolgensma, Oncologic Piqray
12:43 EDT 26 May 2019 |
SCRIP
The latest drug development news and highlights from our US FDA Performance Tracker.
More From BioPortfolio on "Keeping Track: Novartis Scores Big Ahead Of US Memorial Day With Approvals For Gene Therapy Zolgensma, Oncologic Piqray"